Compartilhar
Informação da revista
Mais popular
Artigos que receberam mais atenção nas mídias sociais. Número de vezes que foram referenciados nos últimos 3 anos.
846
Equity program: strategies on clinical studies as an aggregating potentialEdvan de Queiroz Crusoe, Abrahão Elias Hallack Neto, Deise Ferreira Nantes, Eduardo Flavio Oliveira Ribeiro, Fernando Monteiro Correia Pinto, Jaisson Andre Pagnoncelli Bortolini, James Farley Rafael Maciel, Jose Francisco Comenalli Marques Junior, ... Renato Luiz Guerino Cunha
Hematol Transfus Cell Ther. 2023;45:417-8
846
Acesso de texto completo
264
Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literatureBruno Almeida Costa, Kaiza Vilarinho da Luz, Sarah Emanuelle Viana Campos, Germison Silva Lopes, João Paulo de Vasconcelos Leitão, Fernando Barroso Duarte
Hematol Transfus Cell Ther. 2022;44:26-31
264
Open access
207
Progressive multifocal leukoencephalopathy in a patient with relapsed chronic lymphocytic leukemia treated with IbrutinibLarissa Lane Cardoso Teixeira, Viviane Regina Hernandez Nunes, Guilherme Fleury Perini, Carolina Cristina Pellegrino Feres, Danielle Ovigli, Nelson Hamerschlak
Hematol Transfus Cell Ther. 2022;44:437-9
207
Open access
147
Hemoglobin value may be decreased in patients with severe coronavirus disease 2019Giuseppe Lippi, Camilla Mattiuzzi
Hematol Transfus Cell Ther. 2020;42:116-7
147
Open access
Artigo aberto
134
GATA2 variants in patients with non-tuberculous mycobacterial or fungal infections without known immunodeficienciesDaniela P. Mendes-de-Almeida, Francianne G. Andrade, Filipe V. dos Santos-Bueno, Dayvison F. Saraiva Freitas, Sheila C. Soares-Lima, Rosely M. Zancopé-Oliveira, Maria S. Pombo-de-Oliveira
Hematol Transfus Cell Ther. 2023;45:211-6
134
Acesso de texto completo
117
A functional interaction between the CCR5 and CD34 molecules expressed in hematopoietic cells can support (or even promote) the development of cancerBruna Kulmann-Leal, Joel Henrique Ellwanger, José Artur Bogo Chies
Hematol Transfus Cell Ther. 2020;42:70-6
117
Open access
89
Plan for blood banks to protect blood donors and healthcare workers during COVID-19 pandemicSheikh Muhammad Ebad Ali, Sarosh Fatima
Hematol Transfus Cell Ther. 2020;42:316-7
89
Open access
Artigo aberto
87
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendationGuilherme Fleury Perini, Thais Fischer, Rafael Dezen Gaiolla, Talita Bueno Rocha, Marcelo Bellesso, Larissa Lane Cardoso Teixeira, Marcia Torresan Delamain, Adriana Alves de Souza Scheliga, ... on Behalf of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH)
Hematol Transfus Cell Ther. 2020;42:103-10
87
Open access
73
High prevalence of serological weak D phenotype and preponderance of weak D type 4.0.1. genetic variant in a Nigerian population: implications for transfusion practice in a resource-limited settingDauda Usman Maryam, Isyaku Gwarzo Mukhtar, Aminu Abba Yusuf, Ahmed Ibrahim Salisu
Hematol Transfus Cell Ther. 2022;44:386-91
73
Open access
67
PILOMATRIX CARCINOMA WAS BEYOND ANY EXPECTATIONS: A CASE REPORT OF CARCINOMA CLINICIAN SHOULD BE AWARE OF ITAbdalraouf Omar, Suad Elnnami, Ibtihaj Hassan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52
67
Open access
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.